GAFFX
Price
$77.04
Change
-$0.14 (-0.18%)
Updated
Sep 20 closing price
JRACX
Price
$71.96
Change
-$0.21 (-0.29%)
Updated
Sep 20 closing price
Ad is loading...

GAFFX vs JRACX

Header iconGAFFX vs JRACX Comparison
Open Charts GAFFX vs JRACXBanner chart's image
American Funds Growth Fund of Amer F3
Price$77.04
Change-$0.14 (-0.18%)
VolumeN/A
CapitalizationN/A
Janus Henderson Research C
Price$71.96
Change-$0.21 (-0.29%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GAFFX vs JRACX Comparison Chart
Loading...
VS
GAFFX vs. JRACX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and JRACX is a Buy.

FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 290B vs. JRACX (23.3B). GAFFX pays higher dividends than JRACX: GAFFX (0.75) vs JRACX (0.00). GAFFX was incepted earlier than JRACX: GAFFX (8 years) vs JRACX (15 years). GAFFX is a more actively managed with annual turnover of: 31.00 vs. JRACX (27.00). JRACX has a lower initial minimum investment than GAFFX: JRACX (2500) vs GAFFX (1000000). JRACX annual gain was more profitable for investors over the last year : 38.98 vs. GAFFX (30.65). GAFFX (55.06) and JRACX (54.77) have equivalent 5 years return.
GAFFXJRACXGAFFX / JRACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years15 years-
Gain YTD21.99526.37083%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets290B23.3B1,245%
Annual Yield % from dividends0.750.00-
Returns for 1 year30.6538.9879%
Returns for 3 years1.289.4314%
Returns for 5 years55.0654.77101%
Returns for 10 yearsN/A58.21-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FLR47.19-0.26
-0.55%
Fluor Corp
ERO21.00-0.44
-2.05%
Ero Copper Corp
CAC40.18-0.87
-2.12%
Camden National Corp
APVO0.17-0.01
-3.35%
Aptevo Therapeutics
VCSA3.90-0.31
-7.36%
Vacasa